{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:45:59Z","timestamp":1791773159890,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the special project of the key research and development tasks of Xinjiang Uygur autonomous region","award":["No. 2022B03005-2"],"award-info":[{"award-number":["No. 2022B03005-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"DOI":"10.1186\/s12864-025-11668-w","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:50:47Z","timestamp":1747338647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis"],"prefix":"10.1186","volume":"26","author":[{"given":"Ruofan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"6","key":"11668_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"1","key":"11668_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"11668_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"11668_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","volume":"65","author":"R Pais","year":"2016","unstructured":"Pais R, Barritt ASt, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. NAFLD and liver transplantation: current burden and expected challenges. J Hepatol. 2016;65(6):1245\u201357.","journal-title":"J Hepatol"},{"issue":"2","key":"11668_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00125-019-05024-3","volume":"63","author":"M Brouwers","year":"2020","unstructured":"Brouwers M, Simons N, Stehouwer CDA, Isaacs A. Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality. Diabetologia. 2020;63(2):253\u201360.","journal-title":"Diabetologia"},{"issue":"14","key":"11668_CR6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341\u201350.","journal-title":"N Engl J Med"},{"issue":"9","key":"11668_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599\u2013612.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11668_CR8","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020;42:101092.","journal-title":"Mol Metab"},{"issue":"7","key":"11668_CR9","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagstr\u00f6m H, Yoon SK, Charatcharoenwitthaya P, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680.","journal-title":"PLoS Med"},{"issue":"1 Suppl","key":"11668_CR10","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364.","journal-title":"J Hepatol"},{"issue":"5","key":"11668_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. The economic and clinical burden of nonalcoholic fatty liver disease in the united States and Europe. Hepatology. 2016;64(5):1577\u201386.","journal-title":"Hepatology"},{"issue":"10","key":"11668_CR12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1136\/gutjnl-2019-319104","volume":"69","author":"JF Dufour","year":"2020","unstructured":"Dufour JF, Caussy C, Loomba R. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. Gut. 2020;69(10):1877\u201384.","journal-title":"Gut"},{"issue":"22","key":"11668_CR13","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA. 2015;313(22):2263\u201373.","journal-title":"JAMA"},{"issue":"1","key":"11668_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"12","key":"11668_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461\u20135.","journal-title":"Nat Genet"},{"issue":"3","key":"11668_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ajg.2013.476","volume":"109","author":"AG Singal","year":"2014","unstructured":"Singal AG, Manjunath H, Yopp AC, Beg MS, Marrero JA, Gopal P, Waljee AK. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(3):325\u201334.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"11668_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybj\u00e6rg-Hansen A, Vogt TF, Hobbs HH, Cohen JC. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46(4):352\u20136.","journal-title":"Nat Genet"},{"issue":"4","key":"11668_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng.2926","volume":"46","author":"OL Holmen","year":"2014","unstructured":"Holmen OL, Zhang H, Fan Y, Hovelson DH, Schmidt EM, Zhou W, Guo Y, Zhang J, Langhammer A, L\u00f8chen ML, et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat Genet. 2014;46(4):345\u201351.","journal-title":"Nat Genet"},{"key":"11668_CR19","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1038\/ncomms5309","volume":"5","author":"YL Liu","year":"2014","unstructured":"Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, Allison ME, Alexander GJ, Piguet AC, Anty R, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:4309.","journal-title":"Nat Commun"},{"issue":"5","key":"11668_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, Pingitore P, Meroni M, Rametta R, Bor\u00e9n J, Montalcini T, Pujia A, Wiklund O, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology. 2016;150(5):1219\u2013e12301216.","journal-title":"Gastroenterology"},{"issue":"6","key":"11668_CR21","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2016.07.045","volume":"65","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen PK, Zhou Y, Hy\u00f6tyl\u00e4inen T, Leivonen M, Arola J, Orho-Melander M, Ore\u0161i\u010d M, Yki-J\u00e4rvinen H. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans. J Hepatol. 2016;65(6):1263\u20135.","journal-title":"J Hepatol"},{"issue":"3","key":"11668_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/hep.24806","volume":"55","author":"N Santoro","year":"2012","unstructured":"Santoro N, Zhang CK, Zhao H, Pakstis AJ, Kim G, Kursawe R, Dykas DJ, Bale AE, Giannini C, Pierpont B, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology. 2012;55(3):781\u20139.","journal-title":"Hepatology"},{"issue":"3","key":"11668_CR23","doi-asserted-by":"publisher","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","volume":"7","author":"EK Speliotes","year":"2011","unstructured":"Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7(3):e1001324.","journal-title":"PLoS Genet"},{"issue":"12","key":"11668_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","volume":"378","author":"NS Abul-Husn","year":"2018","unstructured":"Abul-Husn NS, Cheng X, Li AH, Xin Y, Schurmann C, Stevis P, Liu Y, Kozlitina J, Stender S, Wood GC, et al. A Protein-Truncating HSD17B13 variant and protection from chronic liver disease. N Engl J Med. 2018;378(12):1096\u2013106.","journal-title":"N Engl J Med"},{"issue":"3","key":"11668_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2015.10.016","volume":"64","author":"S Petta","year":"2016","unstructured":"Petta S, Valenti L, Marra F, Grimaudo S, Tripodo C, Bugianesi E, Camm\u00e0 C, Cappon A, Di Marco V, Di Maira G, et al. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2016;64(3):682\u201390.","journal-title":"J Hepatol"},{"issue":"6099","key":"11668_CR26","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1222794","volume":"337","author":"MT Maurano","year":"2012","unstructured":"Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337(6099):1190\u20135.","journal-title":"Science"},{"issue":"6","key":"11668_CR27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41588-020-0625-2","volume":"52","author":"DW Yao","year":"2020","unstructured":"Yao DW, O\u2019Connor LJ, Price AL, Gusev A. Quantifying genetic effects on disease mediated by assayed gene expression levels. Nat Genet. 2020;52(6):626\u201333.","journal-title":"Nat Genet"},{"issue":"1","key":"11668_CR28","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/s41467-024-46064-7","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Wang Z, Gong L, Wang Q, Chen W, Wang J, Ma X, Ding R, Li X, Zou X, et al. A distinct class of pan-cancer susceptibility genes revealed by an alternative polyadenylation transcriptome-wide association study. Nat Commun. 2024;15(1):1729.","journal-title":"Nat Commun"},{"issue":"7539","key":"11668_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJ, Shishkin AA, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337\u201343.","journal-title":"Nature"},{"issue":"7858","key":"11668_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41586-021-03446-x","volume":"593","author":"J Nasser","year":"2021","unstructured":"Nasser J, Bergman DT, Fulco CP, Guckelberger P, Doughty BR, Patwardhan TA, Jones TR, Nguyen TH, Ulirsch JC, Lekschas F, et al. Genome-wide enhancer maps link risk variants to disease genes. Nature. 2021;593(7858):238\u201343.","journal-title":"Nature"},{"issue":"1","key":"11668_CR31","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/s41467-023-41690-z","volume":"14","author":"P Ying","year":"2023","unstructured":"Ying P, Chen C, Lu Z, Chen S, Zhang M, Cai Y, Zhang F, Huang J, Fan L, Ning C, et al. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk. Nat Commun. 2023;14(1):5958.","journal-title":"Nat Commun"},{"issue":"7414","key":"11668_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"An integrated encyclopedia","year":"2012","unstructured":"An integrated encyclopedia. Of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374.","journal-title":"Nature"},{"issue":"7539","key":"11668_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"A Kundaje","year":"2015","unstructured":"Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller MJ, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317\u201330.","journal-title":"Nature"},{"issue":"12","key":"11668_CR34","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-019-0538-0","volume":"51","author":"CP Fulco","year":"2019","unstructured":"Fulco CP, Nasser J, Jones TR, Munson G, Bergman DT, Subramanian V, Grossman SR, Anyoha R, Doughty BR, Patwardhan TA, et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat Genet. 2019;51(12):1664\u20139.","journal-title":"Nat Genet"},{"issue":"13","key":"11668_CR35","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/bioinformatics\/btaa883","volume":"37","author":"D Huang","year":"2021","unstructured":"Huang D, Wang Z, Zhou Y, Liang Q, Sham PC, Yao H, Li MJ. vSampler: fast and annotation-based matched variant sampling tool. Bioinformatics. 2021;37(13):1915\u20137.","journal-title":"Bioinformatics"},{"issue":"2","key":"11668_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80\u201392.","journal-title":"Fly (Austin)"},{"issue":"1","key":"11668_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"D1","key":"11668_CR38","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"11668_CR39","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, Haw R, Jassal B, Matthews L, May B, et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52(D1):D672\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"11668_CR40","doi-asserted-by":"publisher","first-page":"D1301","DOI":"10.1093\/nar\/gkr1074","volume":"40","author":"T Kelder","year":"2012","unstructured":"Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, Evelo CT, Pico AR. WikiPathways: Building research communities on biological pathways. Nucleic Acids Res. 2012;40(Database issue):D1301\u20131307.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"11668_CR41","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","volume":"51","author":"L Kolberg","year":"2023","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, Peterson H. g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 2023;51(W1):W207\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"11668_CR42","doi-asserted-by":"publisher","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","volume":"52","author":"M Cannon","year":"2024","unstructured":"Cannon M, Stevenson J, Stahl K, Basu R, Coffman A, Kiwala S, McMichael JF, Kuzma K, Morrissey D, Cotto K, et al. DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 2024;52(D1):D1227\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"7289","key":"11668_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nature08872","volume":"464","author":"JK Pickrell","year":"2010","unstructured":"Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, Nkadori E, Veyrieras JB, Stephens M, Gilad Y, Pritchard JK. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature. 2010;464(7289):768\u201372.","journal-title":"Nature"},{"key":"11668_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2018.10.026","volume":"566","author":"ML Sowers","year":"2019","unstructured":"Sowers ML, Herring J, Zhang W, Tang H, Ou Y, Gu W, Zhang K. Analysis of glucose-derived amino acids involved in one-carbon and cancer metabolism by stable-isotope tracing gas chromatography mass spectrometry. Anal Biochem. 2019;566:1\u20139.","journal-title":"Anal Biochem"},{"issue":"1","key":"11668_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ajcn\/83.1.5","volume":"83","author":"LM Stead","year":"2006","unstructured":"Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to Reevaluate Methyl balance in humans? Am J Clin Nutr. 2006;83(1):5\u201310.","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"11668_CR46","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/bjc.2017.118","volume":"116","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK. One-carbon metabolism in cancer. Br J Cancer. 2017;116(12):1499\u2013504.","journal-title":"Br J Cancer"},{"issue":"4","key":"11668_CR47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1055\/a-0784-8827","volume":"57","author":"E Roeb","year":"2019","unstructured":"Roeb E, Geier A. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. Z Gastroenterol. 2019;57(4):508\u201317.","journal-title":"Z Gastroenterol"},{"issue":"10213","key":"11668_CR48","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","volume":"394","author":"SA Harrison","year":"2019","unstructured":"Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, et al. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2019;394(10213):2012\u201324.","journal-title":"Lancet"},{"issue":"18","key":"11668_CR49","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675\u201385.","journal-title":"N Engl J Med"},{"issue":"5","key":"11668_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","volume":"54","author":"V Ratziu","year":"2011","unstructured":"Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol. 2011;54(5):1011\u20139.","journal-title":"J Hepatol"},{"issue":"32","key":"11668_CR51","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3748\/wjg.v11.i32.5053","volume":"11","author":"JG Fan","year":"2005","unstructured":"Fan JG, Xu ZJ, Wang GL. Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model. World J Gastroenterol. 2005;11(32):5053\u20136.","journal-title":"World J Gastroenterol"},{"key":"11668_CR52","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1038\/ncomms4083","volume":"5","author":"A Mardinoglu","year":"2014","unstructured":"Mardinoglu A, Agren R, Kampf C, Asplund A, Uhlen M, Nielsen J. Genome-scale metabolic modelling of hepatocytes reveals Serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:3083.","journal-title":"Nat Commun"},{"issue":"9","key":"11668_CR53","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/thy.2018.0664","volume":"29","author":"RA Sinha","year":"2019","unstructured":"Sinha RA, Bruinstroop E, Singh BK, Yen PM. Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid. 2019;29(9):1173\u201391.","journal-title":"Thyroid"},{"issue":"11","key":"11668_CR54","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1210\/en.2014-1302","volume":"155","author":"BN Bohinc","year":"2014","unstructured":"Bohinc BN, Michelotti G, Xie G, Pang H, Suzuki A, Guy CD, Piercy D, Kruger L, Swiderska-Syn M, Machado M, et al. Repair-related activation of Hedgehog signaling in stromal cells promotes intrahepatic hypothyroidism. Endocrinology. 2014;155(11):4591\u2013601.","journal-title":"Endocrinology"},{"issue":"10","key":"11668_CR55","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2018-00999","volume":"103","author":"M Pietzner","year":"2018","unstructured":"Pietzner M, Budde K, Homuth G, Kastenm\u00fcller G, Henning AK, Artati A, Krumsiek J, V\u00f6lzke H, Adamski J, Lerch MM, et al. Hepatic steatosis is associated with adverse molecular signatures in subjects without diabetes. J Clin Endocrinol Metab. 2018;103(10):3856\u201368.","journal-title":"J Clin Endocrinol Metab"},{"key":"11668_CR56","doi-asserted-by":"crossref","unstructured":"Hasegawa T, Iino C, Endo T, Mikami K, Kimura M, Sawada N, Nakaji S, Fukuda S. Changed amino acids in NAFLD and liver fibrosis: A large Cross-Sectional study without influence of insulin resistance. Nutrients. 2020;12(5).","DOI":"10.3390\/nu12051450"},{"key":"11668_CR57","doi-asserted-by":"crossref","unstructured":"Markowska J, Kasprzak-Drozd K, Nizi\u0144ski P, Dragan M, Kondracka A, Gondek E, Oniszczuk T, Oniszczuk A. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules. 2024;29(22).","DOI":"10.3390\/molecules29225245"},{"issue":"Pt 3","key":"11668_CR58","doi-asserted-by":"publisher","first-page":"116610","DOI":"10.1016\/j.bcp.2024.116610","volume":"230","author":"Z Wang","year":"2024","unstructured":"Wang Z, Gao P, Gao J, Liang B, Ma Q, Sun Q, Hu Y, Wang Y, Peng Y, Liu H, et al. Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in Ob\/ob mice. Biochem Pharmacol. 2024;230(Pt 3):116610.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"11668_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5005\/jp-journals-10018-1434","volume":"14","author":"VS Patel","year":"2024","unstructured":"Patel VS, Mahmood SF, Bhatt KH, Khemkar RM, Jariwala DR, Harris B, George MM, Kurudamannil RA, Anyagwa OE, Tak RS, et al. Ursodeoxycholic acid\u2019s effectiveness in the management of nonalcoholic fatty liver disease: A systematic review and Meta-analysis. Euroasian J Hepatogastroenterol. 2024;14(1):92\u20138.","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"11668_CR60","doi-asserted-by":"crossref","unstructured":"Kogiso T, Ogasawara Y, Taniai M, Shimada E, Inai K, Tokushige K, Nakai Y. Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease. J Gastroenterol 2024.","DOI":"10.1007\/s00535-024-02168-x"},{"issue":"11","key":"11668_CR61","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.970","volume":"43","author":"JC Chambers","year":"2011","unstructured":"Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, Holm H, Sanna S, Kavousi M, Baumeister SE, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 2011;43(11):1131\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"11668_CR62","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1038\/s41467-023-38430-8","volume":"14","author":"H Yan","year":"2023","unstructured":"Yan H, Wu W, Hu Y, Li J, Xu J, Chen X, Xu Z, Yang X, Yang B, He Q, et al. Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK\/MDM2\/p53 axis. Nat Commun. 2023;14(1):2756.","journal-title":"Nat Commun"},{"key":"11668_CR63","doi-asserted-by":"publisher","first-page":"156047","DOI":"10.1016\/j.phymed.2024.156047","volume":"135","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ran T, Li S, Han L, Chen S, Lin G, Wu H, Wu H, Feng S, Chen J, et al. Catalpol ameliorates liver fibrosis via inhibiting aerobic Glycolysis by EphA2\/FAK\/Src signaling pathway. Phytomedicine. 2024;135:156047.","journal-title":"Phytomedicine"},{"issue":"2","key":"11668_CR64","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song SJ, Lai JC, Wong GL, Wong VW, Yip TC. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80(2):e54\u20136.","journal-title":"J Hepatol"},{"key":"11668_CR65","doi-asserted-by":"crossref","unstructured":"Aizarani N, Saviano A, Sagar, Mailly L, Durand S, Herman JS, Pessaux P, Baumert TF. Gr\u00fcn D: A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature. 2019;572(7768):199\u2013204.","DOI":"10.1038\/s41586-019-1373-2"},{"issue":"6","key":"11668_CR66","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","volume":"72","author":"E Tr\u00e9po","year":"2020","unstructured":"Tr\u00e9po E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020;72(6):1196\u2013209.","journal-title":"J Hepatol"},{"issue":"2","key":"11668_CR67","doi-asserted-by":"publisher","first-page":"e0229374","DOI":"10.1371\/journal.pone.0229374","volume":"15","author":"JY Seo","year":"2020","unstructured":"Seo JY, Lee JE, Chung GE, Shin E, Kwak MS, Yang JI, Yim JY. A genome-wide association study on liver enzymes in Korean population. PLoS ONE. 2020;15(2):e0229374.","journal-title":"PLoS ONE"},{"issue":"4","key":"11668_CR68","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","volume":"83","author":"X Yuan","year":"2008","unstructured":"Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, Zhang W, Vollenweider P, Stirnadel H, Johnson T, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet. 2008;83(4):520\u20138.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"11668_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","volume":"17","author":"Y Honda","year":"2017","unstructured":"Honda Y, Kessoku T, Sumida Y, Kobayashi T, Kato T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, et al. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol. 2017;17(1):96.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"11668_CR70","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep4.1906","volume":"6","author":"V \u0160m\u00edd","year":"2022","unstructured":"\u0160m\u00edd V, Dvo\u0159\u00e1k K, \u0160ediv\u00fd P, Kosek V, Len\u00ed\u010dek M, Dezortov\u00e1 M, Haj\u0161lov\u00e1 J, H\u00e1jek M, V\u00edtek L, Bechy\u0148sk\u00e1 K, et al. Effect of Omega-3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome and NAFLD. Hepatol Commun. 2022;6(6):1336\u201349.","journal-title":"Hepatol Commun"},{"issue":"1","key":"11668_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, Yang J. 10 Years of GWAS discovery: biology, function, and translation. Am J Hum Genet. 2017;101(1):5\u201322.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"11668_CR72","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2344","volume":"9","author":"MI McCarthy","year":"2008","unstructured":"McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9(5):356\u201369.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"11668_CR73","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, Jansen R, de Geus EJ, Boomsma DI, Wright FA, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48(3):245\u201352.","journal-title":"Nat Genet"},{"issue":"4","key":"11668_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrg.2016.12","volume":"17","author":"MR Nelson","year":"2016","unstructured":"Nelson MR, Johnson T, Warren L, Hughes AR, Chissoe SL, Xu CF, Waterworth DM. The genetics of drug efficacy: opportunities and challenges. Nat Rev Genet. 2016;17(4):197\u2013206.","journal-title":"Nat Rev Genet"},{"key":"11668_CR75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mrrev.2019.04.001","volume":"781","author":"C P\u00e9rez-Ram\u00edrez","year":"2019","unstructured":"P\u00e9rez-Ram\u00edrez C, Ca\u00f1adas-Garre M, Molina M, Cabeza Barrera J, Faus-D\u00e1der MJ. Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients. Mutat Res Rev Mutat Res. 2019;781:63\u201370.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"5","key":"11668_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14740\/wjon1405","volume":"12","author":"AC Gummadi","year":"2021","unstructured":"Gummadi AC, Guddati AK. Genetic polymorphisms in pharmaceuticals and chemotherapy. World J Oncol. 2021;12(5):149\u201354.","journal-title":"World J Oncol"},{"issue":"1","key":"11668_CR77","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12920-023-01685-7","volume":"16","author":"L Sun","year":"2023","unstructured":"Sun L, Wu Z, Lin Y, Xu S, Ye Y, Yin W, Zhou L, Lu J. Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients. BMC Med Genomics. 2023;16(1):267.","journal-title":"BMC Med Genomics"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-11668-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-025-11668-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-11668-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T21:02:50Z","timestamp":1747342970000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-025-11668-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11668"],"URL":"https:\/\/doi.org\/10.1186\/s12864-025-11668-w","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the original studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}